Involvement of central cholinergic system in decrease of serum fatty acids after intracerebroventricular administration of chlorpromazine.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001921:Brain / Q000187:drug effects*; D002217:Carbachol / Q000494:pharmacology; D002746:Chlorpromazine / Q000008:administration & dosage / Q000494:pharmacology*; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D007276:Injections, Intraventricular; D008297:Male; D009388:Neostigmine / Q000494:pharmacology; D010275:Parasympathetic Nervous System / Q000187:drug effects*; D051381:Rats; D011919:Rats, Inbred Strains
D002800:Cholinesterase Inhibitors; D005230:Fatty Acids, Nonesterified; D009388:Neostigmine; D001285:Atropine; D002217:Carbachol; D000109:Acetylcholine; D002746:Chlorpromazine